Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats

被引:25
|
作者
Ikeda, Y
Nakamura, T [1 ]
Takano, H
Kimura, H
Obata, JE
Takeda, S
Hata, A
Shido, K
Mochizuki, S
Yoshida, Y
机构
[1] Yamanashi Med Univ, Div Blood Transfus, Yamanashi 4093898, Japan
[2] Yamanashi Med Univ, Dept Internal Med, Yamanashi 4093898, Japan
[3] Yamanashi Med Univ, Dept Pathol, Yamanashi 4093898, Japan
[4] Hokkaido Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 060, Japan
[5] Jikei Univ, Sch Med, Aoto Hosp, Dept Med, Tokyo, Japan
来源
关键词
D O I
10.1067/mlc.2000.105617
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Angiotensin-converting enzyme inhibitors (ACEIs) cause regression of hypertensive left ventricular hypertrophy (LVH) by reducing angiotensin II, increasing bradykinin, or both. The mechanisms of these cardioprotective effects remain controversial. The aims of this study were to determine whether the cardioprotective effects of ACEIs are mediated by reducing angiotensin II and whether ACEIs ameliorate the morphologic, physiologic, and biochemical changes in the hearts of stroke-prone spontaneously hypertensive rats (SHRSPs). Male SHRSPs were treated with hydralazine, captopril, or candesartan, an angiotensin II type 1 receptor(AT1R) antagonist, from age 12 to 24 weeks. We measured systolic blood pressure (SBP), left ventricular weight (LVW), left ventricular (LV) myocyte cross-sectional area (myocyte size), LV interstitial collagen volume fraction (ICVF), perivascular collagen area/luminal area ratio (PVCA/LA), the medial area to luminal area ratio (MA/LA), the relative amount of V3 myosin heavy chain (MHCV3), and coronary reserve maximum (coronary flow max/ventricular weight (CFmax/VW)). These parameters were compared with those of untreated SHRSPs and Wistar-Kyoto mts (WKYs). SHRSPs exhibited decreased coronary reserve and LVH with an increase in myocyte size, PVCA/LA, MA/LA, and MHCV3 at 12 weeks of age. In addition to these changes, 24-week-old SHRSPs showed an increase in ICVF. The LVW coronary reserve, myocyte size, PVCA/LA, ICVF, and MHCV3 of SHRSPs treated with captopril or candesartan all approached control values. In contrast, hydralazine decreased only ICVF. These results suggest that ACEIs regress LVH and normalize coronary reserve by modulating the effects of angiotensin II via AT1R on the induction of cardiomyocyte hypertrophy, perivascular fibrosis, and medial thickening of intramyocardial coronary arteries in SHRSPs. We concluded that these effects, in addition to the reduction of SEP, are important in causing the regression of LVH.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 50 条
  • [1] Aldosterone as well as angiotensin II are involved in the cardiac hypertrophy of Stroke-Prone spontaneously hypertensive rats (SHRSP)
    Kimura, H
    Nakamura, T
    Ikeda, Y
    Obata, JE
    Takano, H
    Satoh, T
    Tamura, K
    Yoshida, Y
    CIRCULATION, 1996, 94 (08) : 3852 - 3852
  • [2] Involvement of angiotensin II in glomerulosclerosis of stroke-prone spontaneously hypertensive rats
    Nakamura, T
    Obata, H
    Kuroyanagi, R
    Kimura, H
    Ikeda, Y
    Takano, H
    Naito, A
    Sato, T
    Yoshida, Y
    KIDNEY INTERNATIONAL, 1996, : S109 - S112
  • [3] Sitagliptin Enhances Angiotensin II-Induced Hypertension and Cardiac Hypertrophy in Spontaneously Hypertensive Rats
    Tofovic, David S.
    Bilan, Victor
    Jackson, Edwin K.
    HYPERTENSION, 2009, 54 (04) : E64 - E65
  • [4] Myocyte hypertrophy and capillarization in spontaneously hypertensive stroke-prone rats
    Koyama, T
    Gao, M
    Batra, S
    Togashi, H
    Saito, H
    OXYGEN TRANSPORT TO TISSUE XVIII, 1997, 411 : 365 - 368
  • [5] Benefical effects of pioglitazone on hypertensive cardiac hypertrophy in adult stroke-prone spontaneously hypertensive rats
    Shinzato, T
    Ohya, Y
    Nakamoto, M
    Ishida, A
    Takishita, S
    HYPERTENSION, 2005, 46 (04) : 856 - 856
  • [6] Long-term effects of pioglitazone on cardiac hypertrophy, inflammation and fibrosis in stroke-prone spontaneously hypertensive rats
    Diep, ON
    Benkirane, K
    Schiffrin, EL
    JOURNAL OF HYPERTENSION, 2002, 20 : S6 - S6
  • [7] Long-term effects of pioglitazone on cardiac hypertrophy, inflammation and fibrosis in stroke-prone spontaneously hypertensive rats
    Diep, QN
    Benkirane, K
    Schiffrin, EL
    HYPERTENSION, 2002, 40 (03) : 412 - 412
  • [8] IMPORTANCE OF CARDIAC, BUT NOT VASCULAR, HYPERTROPHY IN THE CARDIAC BAROREFLEX DEFICIT IN SPONTANEOUSLY HYPERTENSIVE AND STROKE-PRONE RATS
    HEAD, GA
    MINAMI, N
    AMERICAN JOURNAL OF MEDICINE, 1992, 92 : S54 - S59
  • [9] Chronopharmacology of Angiotensin II-receptor Blockers in Stroke-Prone Spontaneously Hypertensive Rats
    Liu, Yuwang
    Ushijima, Kentarou
    Ohmori, Masami
    Takada, Makoto
    Tateishi, Masato
    Ando, Hitoshi
    Fujimura, Akio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 (02) : 196 - 204
  • [10] EFFECTS OF DELAPRIL ON STROKE, KIDNEY DYSFUNCTION AND CARDIAC-HYPERTROPHY IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    INADA, Y
    OJIMA, M
    ITOH, K
    SHINO, A
    NISHIKAWA, K
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1995, 21 (02) : 41 - 49